Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126741401 | 12674140 | 1 | I | 2015 | 20160801 | 20160822 | 20160822 | EXP | PHHY2016BR108311 | NOVARTIS | 0.00 | M | Y | 55.00000 | KG | 20160822 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126741401 | 12674140 | 1 | PS | RITALIN | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | 10 MG, QD | U | 10187 | 10 | MG | TABLET | QD | |||||
| 126741401 | 12674140 | 2 | SS | RITALIN | METHYLPHENIDATE HYDROCHLORIDE | 1 | U | 10187 | TABLET | ||||||||||
| 126741401 | 12674140 | 3 | SS | RITALIN | METHYLPHENIDATE HYDROCHLORIDE | 1 | U | 10187 | TABLET | ||||||||||
| 126741401 | 12674140 | 4 | SS | RITALIN LA | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | 40 MG, QD | FA436 | 0 | 40 | MG | EXTENDED RELEASE CAPSULES | QD | |||||
| 126741401 | 12674140 | 5 | SS | RITALIN LA | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | EXTENDED RELEASE CAPSULES | QD | ||||||
| 126741401 | 12674140 | 6 | SS | RITALIN LA | METHYLPHENIDATE HYDROCHLORIDE | 1 | 0 | EXTENDED RELEASE CAPSULES |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126741401 | 12674140 | 1 | Attention deficit/hyperactivity disorder |
| 126741401 | 12674140 | 2 | Disturbance in attention |
| 126741401 | 12674140 | 3 | Distractibility |
| 126741401 | 12674140 | 4 | Attention deficit/hyperactivity disorder |
| 126741401 | 12674140 | 5 | Disturbance in attention |
| 126741401 | 12674140 | 6 | Distractibility |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126741401 | 12674140 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126741401 | 12674140 | Affective disorder | |
| 126741401 | 12674140 | Anxiety | |
| 126741401 | 12674140 | Bipolar disorder | |
| 126741401 | 12674140 | Depression | |
| 126741401 | 12674140 | Drug administered to patient of inappropriate age | |
| 126741401 | 12674140 | Irritability | |
| 126741401 | 12674140 | Malaise | |
| 126741401 | 12674140 | Nervousness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |